Bridget E. Bunner

Array ( [id] => 7336717 [patent_doc_number] => 20040132646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Identification of a novel glutamine transporter' [patent_app_type] => new [patent_app_number] => 10/343116 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9166 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132646.pdf [firstpage_image] =>[orig_patent_app_number] => 10343116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616320 [patent_doc_number] => 07144731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'SCF antibody compositions and methods of using the same' [patent_app_type] => utility [patent_app_number] => 10/353783 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 98 [patent_no_of_words] => 52598 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144731.pdf [firstpage_image] =>[orig_patent_app_number] => 10353783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 719675 [patent_doc_number] => 07049138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Epitope-tagged beta-amyloid precursor protein and DNA encoding the same' [patent_app_type] => utility [patent_app_number] => 10/326049 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 8796 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049138.pdf [firstpage_image] =>[orig_patent_app_number] => 10326049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6821613 [patent_doc_number] => 20030219774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Novel human neurotransmitter transporter' [patent_app_type] => new [patent_app_number] => 10/319315 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 62104 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20030219774.pdf [firstpage_image] =>[orig_patent_app_number] => 10319315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730680 [patent_doc_number] => 20030186870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders' [patent_app_type] => new [patent_app_number] => 10/315445 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7011 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186870.pdf [firstpage_image] =>[orig_patent_app_number] => 10315445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432219 [patent_doc_number] => 20040002079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness' [patent_app_type] => new [patent_app_number] => 10/314790 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8895 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002079.pdf [firstpage_image] =>[orig_patent_app_number] => 10314790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7361691 [patent_doc_number] => 20040091453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Pancreatic langerhans beta cell proliferation promoter and apoptosis inhibitor, and screening of candidate compounds for the e drugs' [patent_app_type] => new [patent_app_number] => 10/297058 [patent_app_country] => US [patent_app_date] => 2002-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13810 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091453.pdf [firstpage_image] =>[orig_patent_app_number] => 10297058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870050 [patent_doc_number] => 20030082739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/300827 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 23795 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082739.pdf [firstpage_image] =>[orig_patent_app_number] => 10300827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166667 [patent_doc_number] => 20040077041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Regulation of human follicle stimulating hormone-like g protein -coupled receptor' [patent_app_type] => new [patent_app_number] => 10/276550 [patent_app_country] => US [patent_app_date] => 2002-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22942 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077041.pdf [firstpage_image] =>[orig_patent_app_number] => 10276550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653091 [patent_doc_number] => 20030105303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Isolated mammalian monocyte cell genes; related reagents' [patent_app_type] => new [patent_app_number] => 10/290631 [patent_app_country] => US [patent_app_date] => 2002-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30663 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105303.pdf [firstpage_image] =>[orig_patent_app_number] => 10290631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330345 [patent_doc_number] => 07510840 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-03-31 [patent_title] => 'Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody' [patent_app_type] => utility [patent_app_number] => 10/280711 [patent_app_country] => US [patent_app_date] => 2002-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 45 [patent_no_of_words] => 98223 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/510/07510840.pdf [firstpage_image] =>[orig_patent_app_number] => 10280711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856166 [patent_doc_number] => 20030129667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Method of diagnosing transmissible spongiform encephalopathies' [patent_app_type] => new [patent_app_number] => 10/278314 [patent_app_country] => US [patent_app_date] => 2002-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6869 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129667.pdf [firstpage_image] =>[orig_patent_app_number] => 10278314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796335 [patent_doc_number] => 20030175208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Neutrokine-alpha and neutrokine-alpha splice variant' [patent_app_type] => new [patent_app_number] => 10/270487 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 189408 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175208.pdf [firstpage_image] =>[orig_patent_app_number] => 10270487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861116 [patent_doc_number] => 20030092124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Isolated G-protein coupled receptors, nucleic acid molecules encoding GPCR proteins, and uses thereof as insecticidal targets' [patent_app_type] => new [patent_app_number] => 10/270333 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 109 [patent_no_of_words] => 18252 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092124.pdf [firstpage_image] =>[orig_patent_app_number] => 10270333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6815128 [patent_doc_number] => 20030074678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/270336 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 69 [patent_figures_cnt] => 69 [patent_no_of_words] => 24125 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20030074678.pdf [firstpage_image] =>[orig_patent_app_number] => 10270336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6778709 [patent_doc_number] => 20030049790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/270144 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20934 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049790.pdf [firstpage_image] =>[orig_patent_app_number] => 10270144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701576 [patent_doc_number] => 20030224456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Method for the detection of compounds that modulate the effects of the obese (OB) protein' [patent_app_type] => new [patent_app_number] => 10/262120 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4598 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 219 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224456.pdf [firstpage_image] =>[orig_patent_app_number] => 10262120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683278 [patent_doc_number] => 20030119142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/246929 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 116 [patent_figures_cnt] => 116 [patent_no_of_words] => 44995 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119142.pdf [firstpage_image] =>[orig_patent_app_number] => 10246929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270344 [patent_doc_number] => 20040058862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Novel polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/246583 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56623 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058862.pdf [firstpage_image] =>[orig_patent_app_number] => 10246583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 694212 [patent_doc_number] => 07070945 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment' [patent_app_type] => utility [patent_app_number] => 10/246383 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7966 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070945.pdf [firstpage_image] =>[orig_patent_app_number] => 10246383 [rel_patent_id] =>[rel_patent_doc_number] =>)